BioCentury | Jun 9, 2017
Financial News

Imagion proposes A$12M Australian IPO

...20, is majority owned by Manhattan Scientifics Inc. (OTCQB:MHTX). Imagion Biosystems Ltd. , Melbourne, Australia Julian Zhu Imagion Biosystems Ltd. Manhattan Scientifics Inc....
BioCentury | Jan 26, 2015
Company News

Manhattan Scientifics management update

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Hired: Robert Proulx as president and COO of Manhattan’s Senior Scientific LLC subsidiary, formerly chief commercial officer and general manager of U.S. operations of Silicon Biosystems...
BioCentury | Dec 8, 2014
Financial News

Manhattan Scientifics completes private placement of common stock and warrants

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Date completed: 2014-11-21 Type: Private placement of common stock and warrants Raised: $2 million Shares: 18 million Price: $0.11 Shares after offering: 513.4 million Investor: Accredited...
BioCentury | Mar 24, 2014
Company News

Azano, Manhattan Scientifics sales and marketing update

...the nanoparticles to have applications in separation, targeting, MRI contrast and magnetic particle imaging (MPI). Manhattan Scientifics'...
...nanoparticles. The partners said financial terms are not disclosed. Azano Pharmaceuticals Inc. , Albuquerque, N.M. Manhattan Scientifics Inc....
BioCentury | Feb 3, 2014
Company News

Manhattan Scientifics, University of Texas MD Anderson Cancer Center deal

...was developed by Edward Flynn, founder and chief scientist of Manhattan Scientifics' Senior Scientific LLC subsidiary. Manhattan Scientifics...
...construction of the instrument. The company said NIH-funded work began in 2002. Senior Scientific said Manhattan Scientifics...
...and committed an additional $2 million to continue commercialization. MD Anderson declined to disclose details. Manhattan Scientifics Inc....
BioCentury | Apr 15, 2013
Financial News

Manhattan Scientifics completes private placement of convertible notes

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Date completed: 4/9/13 Type: Private placement of convertible notes Raised: $1 million Shares outstanding prior: 458.5 million Investors: Individual investors Note: The four-year notes bear 8%...
BioCentury | Mar 8, 2010
Company News

Manhattan Scientifics, Senior Scientific deal

...Scientific's nanoparticle cancer detection technology. Financial terms were not disclosed (see BioCentury, Nov. 2, 2009). Manhattan Scientifics Inc....
BioCentury | Nov 2, 2009
Company News

Manhattan Scientifics, Senior Scientific deal

...On Oct. 20, the companies signed a non-binding letter of intent for Manhattan Scientifics to acquire the...
...Manhattan Scientifics expects to partner the technology. The deal is expected to close in 60 days. Manhattan Scientifics Inc....
Items per page:
1 - 8 of 8
BioCentury | Jun 9, 2017
Financial News

Imagion proposes A$12M Australian IPO

...20, is majority owned by Manhattan Scientifics Inc. (OTCQB:MHTX). Imagion Biosystems Ltd. , Melbourne, Australia Julian Zhu Imagion Biosystems Ltd. Manhattan Scientifics Inc....
BioCentury | Jan 26, 2015
Company News

Manhattan Scientifics management update

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Hired: Robert Proulx as president and COO of Manhattan’s Senior Scientific LLC subsidiary, formerly chief commercial officer and general manager of U.S. operations of Silicon Biosystems...
BioCentury | Dec 8, 2014
Financial News

Manhattan Scientifics completes private placement of common stock and warrants

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Date completed: 2014-11-21 Type: Private placement of common stock and warrants Raised: $2 million Shares: 18 million Price: $0.11 Shares after offering: 513.4 million Investor: Accredited...
BioCentury | Mar 24, 2014
Company News

Azano, Manhattan Scientifics sales and marketing update

...the nanoparticles to have applications in separation, targeting, MRI contrast and magnetic particle imaging (MPI). Manhattan Scientifics'...
...nanoparticles. The partners said financial terms are not disclosed. Azano Pharmaceuticals Inc. , Albuquerque, N.M. Manhattan Scientifics Inc....
BioCentury | Feb 3, 2014
Company News

Manhattan Scientifics, University of Texas MD Anderson Cancer Center deal

...was developed by Edward Flynn, founder and chief scientist of Manhattan Scientifics' Senior Scientific LLC subsidiary. Manhattan Scientifics...
...construction of the instrument. The company said NIH-funded work began in 2002. Senior Scientific said Manhattan Scientifics...
...and committed an additional $2 million to continue commercialization. MD Anderson declined to disclose details. Manhattan Scientifics Inc....
BioCentury | Apr 15, 2013
Financial News

Manhattan Scientifics completes private placement of convertible notes

Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Date completed: 4/9/13 Type: Private placement of convertible notes Raised: $1 million Shares outstanding prior: 458.5 million Investors: Individual investors Note: The four-year notes bear 8%...
BioCentury | Mar 8, 2010
Company News

Manhattan Scientifics, Senior Scientific deal

...Scientific's nanoparticle cancer detection technology. Financial terms were not disclosed (see BioCentury, Nov. 2, 2009). Manhattan Scientifics Inc....
BioCentury | Nov 2, 2009
Company News

Manhattan Scientifics, Senior Scientific deal

...On Oct. 20, the companies signed a non-binding letter of intent for Manhattan Scientifics to acquire the...
...Manhattan Scientifics expects to partner the technology. The deal is expected to close in 60 days. Manhattan Scientifics Inc....
Items per page:
1 - 8 of 8